Approval · Notice of Compliance 36350 · 2025
SPC-FENOFIBRATE E: Notice of Compliance 36350
Issued November 7, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36350
- Date
- November 7, 2025
- Company
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Change in product name
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPC-FENOFIBRATE E | 02454696 | Marketed |
Medicinal ingredients
- FENOFIBRATE 145 MG per TAB